Amjad Kanj
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- COVID-19 Clinical Research Studies
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Respiratory Support and Mechanisms 2
- Pleural and Pulmonary Diseases 2
- Cystic Fibrosis Research Advances 2
-
- Antifungal resistance and susceptibility 3
- Co-authors
- Nadine Abdallah (3 shared papers)Ayman O. Soubani (4 shared papers)Nadim Kanj (4 shared papers)Omar Chehab (11 shared papers)Said El Zein (7 shared papers)Hussam Tabaja (6 shared papers)Joseph H. Skalski (2 shared papers)Hossein Salimnia (2 shared papers)
- Journals
- Respiratory Medicine (4 papers)Mayo Clinic Proceedings (2 papers)Open Forum Infectious Diseases (2 papers)Nicotine & Tobacco Research (1 paper)Respiration (1 paper)
- Partner nations
- United StatesLebanonItaly
In The Last Decade
Amjad Kanj
25 papers receiving 337 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 130
- Microbiology 3
- Hematology 31
- Epidemiology 79
- Endocrinology 13
Countries citing papers authored by Amjad Kanj
This map shows the geographic impact of Amjad Kanj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amjad Kanj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amjad Kanj more than expected).
Fields of papers citing papers by Amjad Kanj
This network shows the impact of papers produced by Amjad Kanj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amjad Kanj. The network helps show where Amjad Kanj may publish in the future.
Co-authors
The 25 scholars most cited alongside Amjad Kanj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 98 | |
| 2 | 2014 | 51 | |
| 3 | 2023 | 34 | |
| 4 | 2021 | 31 | |
| 5 | 2022 | 25 | |
| 6 | 2021 | 25 | |
| 7 | 2019 | 13 | |
| 8 | 2024 | 11 | |
| 9 | 2020 | 10 | |
| 10 | 2022 | 6 | |
| 11 | 2019 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2023 | 2 |
About Amjad Kanj
Amjad Kanj is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Physiology, Surgery and Epidemiology, having authored 31 papers that have together received 345 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Antifungal resistance and susceptibility (3 papers), Respiratory Support and Mechanisms (2 papers), Gut microbiota and health (2 papers), Smoking Behavior and Cessation (2 papers), Pleural and Pulmonary Diseases (2 papers) and Cystic Fibrosis Research Advances (2 papers). The work is most often cited by research in Infectious Diseases (130 citations), Microbiology (3 citations), Hematology (31 citations), Epidemiology (79 citations) and Endocrinology (13 citations). Amjad Kanj has collaborated with scholars based in United States, Lebanon and Italy. Frequent co-authors include Nadine Abdallah, Ayman O. Soubani, Nadim Kanj, Omar Chehab, Said El Zein, Hussam Tabaja, Joseph H. Skalski, Hossein Salimnia, Misbah Baqir and Maryam Mahmood. Their work appears in journals such as Respiratory Medicine, Mayo Clinic Proceedings, Open Forum Infectious Diseases, Nicotine & Tobacco Research and Respiration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.